Corrigendum to <’Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities’><[European Journal of Medicinal Chemistry, 89 (2015) 540-548]> (European Journal of Medicinal Chemistry, (2015) 89 (540-548) (S0223523414010009), (10.1016/j.ejmech.2014.10.072));Design, synthesis and biological evaluation of novel peptides with anti-cancer and drug resistance-reversing activities

European Journal of Medicinal Chemistry

Volumn 89, Issue , 2015, Pages 540-548

  Deng, Xin ^a   Qiu, Qianqian ^a   Yang, Baowei ^a   Wang, Xuekun ^a   Huang, Wenlong ^a   Qian, Hai ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anti cancer; Drug resistance reversing effects; Membrane disruption; Peptides

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOCHROME C; DOXORUBICIN; PEPTIDE DERIVATIVE; VERAPAMIL; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG DESIGN; DRUG PURIFICATION; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IC50; IN VITRO STUDY; MIGRATION INHIBITION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NONHUMAN; PHYSICAL CHEMISTRY; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ANIMAL; CELL MOTION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; MCF 7 CELL LINE; RABBIT; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL MOVEMENT; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; ERYTHROCYTES; HEMOLYSIS; HUMANS; MCF-7 CELLS; PEPTIDES; RABBITS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 84908407732     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2022.114107     Document Type: Erratum

References (38)

1. N. Beaulieu D. Bloom R. Bloom R. Stein Breakaway: the Global Burden of Cancer-Challenges and Opportunities 2009 The Economist Intelligence Unit
2. R.J. Boohaker M.W. Lee P. Vishnubhotla J.M. Perez A.R. Khaled The use of therapeutic peptides to target and to kill cancer cells Curr. Med. Chem. 19 22 2011 3794 3804
3. M.R. Stratton P.J. Campbell P.A. Futreal The cancer genome Nature 458 7239 2009 719 724
4. R. Beaglehole R. Bonita R. Magnusson Global cancer prevention: an important pathway to global health and development Public Health 125 12 2011 821 831
5. A. Coates S. Abraham S.B. Kaye T. Sowerbutts C. Frewin R.M. Fox M.H.N. Tattersall On the receiving end-patient perception of the side-effects of cancer chemotherapy Eur. J. Cancer Clin. Oncol. 19 2 1983 203 208
6. M. Monje J. Dietrich Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis Behav. Brain Res. 227 2 2012 376 379
7. J.J. Monsuez J.C. Charniot N. Vignat J.Y. Artigou Cardiac side-effects of cancer chemotherapy Int. J. Cardiol. 144 1 2010 3 15
8. M.R. Yeaman N.Y. Yount Mechanisms of antimicrobial peptide action and resistance Pharmacol. Rev. 55 1 2003 27 55
9. K. Splith I. Neundorf Antimicrobial peptides with cell-penetrating peptide properties and vice versa Eur. Biophys. J. 40 4 2011 387 397
10. R.E. Hancock A. Rozek Role of membranes in the activities of antimicrobial cationic peptides FEMS Microbiol. Lett. 206 2 2002 143 149
11. N.Y. Yount A.S. Bayer Y.Q. Xiong M.R. Yeaman Advances in antimicrobial peptide immunobiology Peptide Sci. 84 5 2006 435 458
12. D.W. Hoskin A. Ramamoorthy Studies on anticancer activities of antimicrobial peptides Biochim. Biophys. Acta-Biomembr. 1778 2 2008 357 375
13. J.S. Mader D.W. Hoskin Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment Expert Opin. Invest. Drugs 15 8 2006 933 946
14. K.R. Wang J.X. Yan B.Z. Zhang J.J. Song P.F. Jia R. Wang Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells Cancer Lett. 278 1 2009 65 72
15. T. Utsugi A.J. Schroit J. Connor C.D. Bucana I.J. Fidler Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes Cancer Res. 51 11 1991 3062 3066
16. W.H. Yoon H.D. Park K. Lim B.D. Hwang Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells Biochem. Biophys. Res. Commun. 222 3 1996 694 699
17. M.D. Burdick A. Harris C.J. Reid T. Iwamura M.A. Hollingsworth Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines J. Biol. Chem. 272 39 1997 24198 24202
18. I. DobrzyÅ.,ska B. Szachowicz-Petelska S. Sulkowski Z. Figaszewski Changes in electric charge and phospholipids composition in human colorectal cancer cells Mol. Cell. Biochem. 276 1-2 2005 113 119
19. A. Zachowski Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement Biochem. J. 294 Pt 1 1993 1 14
20. J.C. Mai Z. Mi S.H. Kim B. Ng P.D. Robbins A proapoptotic peptide for the treatment of solid tumors Cancer Res. 61 21 2001 7709 7712
21. W. Chen B. Yang H. Zhou L. Sun J. Dou H. Qian W. Huang Y. Mei J. Han Structure-activity relationships of a snake cathelicidin-related peptide, BF-15 Peptides 32 12 2011 2497 2503
22. Y. Shai Z. Oren Diastereomers of cytolysins, a novel class of potent antibacterial peptides J. Biol. Chem. 271 13 1996 7305 7308
23. C. Bechara S. Sagan Cell-penetrating peptides: 20years later, where do we stand? FEBS Lett. 587 12 2013 1693 1702
24. P. Grieco V. Luca L. Auriemma A. Carotenuto M.R. Saviello P. Campiglia D. Barra E. Novellino M.L. Mangoni Alanine scanning analysis and structure-function relationships of the frog-skin antimicrobial peptide temporin-1Ta J. Peptide Sci. 17 5 2011 358 365
25. J. Howl Peptide Synthesis and Applications vol. 31 2005 Humana Press Totowa, NJ
26. R. Gautier D. Douguet B. Antonny G. Drin HELIQUEST: a web server to screen sequences with specific±-helical properties Bioinformatics 24 18 2008 2101 2102
27. P.A. Wender D.J. Mitchell K. Pattabiraman E.T. Pelkey L. Steinman J.B. Rothbard The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters Proc. Natl. Acad. Sci. 97 24 2000 13003 13008
28. K.F. Chan I.L. Wong J.W. Kan C.S. Yan L.M. Chow T.H. Chan Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation J. Med. Chem. 55 5 2012 1999 2014
29. Y. Gong Y. Wang F. Chen J. Han J. Miao N. Shao Z. Fang R. Ou Yang Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line Leukemia Res. 24 9 2000 769 774
30. M. Zasloff Antimicrobial peptides of multicellular organisms Nature 415 6870 2002 389 395
31. A. Giuliani G. Pirri S.F. Nicoletto Antimicrobial peptides: an overview of a promising class of therapeutics Central Eur. J. Biol. 2 1 2007 1 33
32. S. Kim S.S. Kim Y.J. Bang S.J. Kim B.J. Lee In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines Peptides 24 7 2003 945 953
33. N. Papo Y. Shai Host defense peptides as new weapons in cancer treatment Cell. Mol. Life Sci. 62 7-8 2005 784 790
34. M.W. Gray Mitochondrial evolution Cold Spring Harb. Perspect. Biol. 4 9 2012 a011403
35. A.I. de Kroon D. Dolis A. Mayer R. Lill B. de Kruijff Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane? Biochim. Biophys. Acta-Biomembr. 1325 1 1997 108 116
36. H. Li S.K. Kolluri J. Gu M.I. Dawson X. Cao P.D. Hobbs B. Lin G.Q. Chen J.S. Lu F. Lin Z. Xie J.A. Fontana J.C. Reed X.K. Zhang Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3 Science 289 5482 2000 1159 1164
37. R. Kim M. Emi K. Tanabe Role of mitochondria as the gardens of cell death Cancer Chemother. Pharmacol. 57 5 2006 545 553
38. P. Borst R. Evers M. Kool J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J. Natl. Cancer Inst. 92 16 2000 1295 1302